Search Results - "Griffith, Madeline J"

Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma by Sinha, Meenal, Betts, Courtney, Zhang, Li, Griffith, Madeline J, Solman, Isabelle, Chen, Brandon, Liu, Eric, Tamaki, Whitney, Stultz, Jacob, Marquez, Jaqueline, Sivagnanam, Shamilene, Cheung, Alexander, Pener, Denise, Fahlman, Anne, Taber, Erin, Lerner, Kimberly, Crocker, Matthew, Todd, Kendra, Rajagopalan, Brindha, Ware, Clarisha, Bridge, Mark, Vo, Johnson, Dragomanovich, Hannah, Sudduth-Klinger, Julie, Vaccaro, Gina, Lopez, Charles D, Tempero, Margaret, Coussens, Lisa M, Fong, Lawrence

“…In preclinical studies of pancreatic ductal adenocarcinoma (PDAC), ibrutinib improved the antitumor efficacy of the standard of care chemotherapy. This led to…”
Get full text

Phase I prospective trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases by Fidelman, Nicholas, Atreya, Chloe Evelyn, Griffith, Madeline J, Milloy, Marion Alexandra, Carnevale, Julia C., Cinar, Pelin, Venook, Alan P., Van Loon, Katherine

“…Abstract only 110 Background: Clinical efficacy of Yttrium-90 ( 90 Y) radioembolization (TARE) for patients with chemotherapy-refractory metastatic colorectal…”
Get full text

Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO) by Keenan, Bridget, Griffith, Madeline J, Bauer, Kelly, Bracci, Paige M., Behr, Spencer, Umetsu, Sarah E, Gordan, John Dozier, Ngo, Zoe, Iqbal, Syma, Hanna, Diana L., Venook, Alan P., El-Khoueiry, Anthony B., Fong, Lawrence, Kelley, Robin Kate

“…Abstract only TPS464 Background: The antiangiogenic tyrosine kinase inhibitor (TKI) SOR prolongs survival in advanced HCC, but responses occur in fewer than 5%…”
Get full text